Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Emma Beltran-Catalan"'
Autor:
José Luis Martín-Varillas, Lara Sanchez-Bilbao, Vanesa Calvo-Río, Alfredo Adán, Inés Hernanz, Adela Gallego-Flores, Emma Beltran-Catalan, Sonia Castro-Oreiro, Patricia Fanlo, Alvaro Garcia Martos, Ignacio Torre, Miguel Cordero-Coma, Juan Ramon De Dios, Ángel García-Aparicio, Marisa Hernández-Garfella, Amalia Sánchez-Andrade, Andrea García-Valle, Olga Maiz, Roberto Miguélez, Sergio Rodríguez-Montero, Ana Urruticoechea, Raúl Veroz, Arantxa Conesa, Cristina Fernández-Carballido, Vega Jovaní, Jose J Mondejar, Olga Martínez González, Patricia Moya Alvarado, Susana Romero-Yuste, Paula Rubio-Muñoz, Eva Peña-Sainz-Pardo, Marta Garijo-Bufort, Rosalía Demetrio-Pablo, José L Hernández, Ricardo Blanco
Publikováno v:
RMD open 2022; 8: e002693
ObjectivesTo evaluate effectiveness and safety of certolizumab pegol (CZP) in uveitis due to immune-mediated inflammatory diseases (IMID).MethodsMulticentre study of CZP-treated patients with IMID uveitis refractory to conventional immunosuppressant.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c28c007d40e41463b8f0de6bee441ca
https://hdl.handle.net/10902/28637
https://hdl.handle.net/10902/28637
Autor:
Emma Beltran-Catalan, Eva Salgado, Marta Valero, José Vicente Moreno-Muelas, Inma Calvo-Penades, Patricia Carreira, Mariluz Garcia-Vivar, Montserrat Romera-Baurés, Agusti Sellas-Fernández, Juan J. Gomez-Reino, Esperanza Naredo, Alina Boteanu
Publikováno v:
Seminars in arthritis and rheumatism. 52
Background In immune-mediated inflammatory rheumatic diseases (IMIRD), there are differences between cis-men and cis-women in epidemiology, clinical feature, therapeutic approach, treatment response, and prognosis. In transgender individuals, informa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac3462e8b829dc76faf4829c9774de48
https://pubmed.ncbi.nlm.nih.gov/36108530
https://pubmed.ncbi.nlm.nih.gov/36108530
Autor:
Ricardo Blanco, Alfredo Adan, Ignacio Torre, Vega Jovani, Susana Romero-Yuste, Arantxa Conesa, Vanesa Calvo-Río, Cristina Fernández-Carballido, Emma Beltrán-Catalán, Patricia Fanlo, Miguel Cordero-Coma, Alvaro Garcia Martos, Ines Hernanz, Angel Garcia-Aparicio, Patricia Moya Alvarado, José Luis Martín-Varillas, Lara Sanchez-Bilbao, Adela Gallego-Flores, Sonia Castro-Oreiro, Juan Ramon De Dios, Marisa Hernández-Garfella, Amalia Sánchez-Andrade, Andrea García-Valle, Olga Maiz, Roberto Miguélez, Sergio Rodríguez-Montero, Ana Urruticoechea, Raúl Veroz, Jose J Mondejar, Olga Martínez González, Paula Rubio-Muñoz, Eva Peña-Sainz-Pardo, Marta Garijo-Bufort, Rosalía Demetrio-Pablo, José L Hernández
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives To evaluate effectiveness and safety of certolizumab pegol (CZP) in uveitis due to immune-mediated inflammatory diseases (IMID).Methods Multicentre study of CZP-treated patients with IMID uveitis refractory to conventional immunosuppressan
Externí odkaz:
https://doaj.org/article/f361c508bc11461bbe86da80df50886e